Young Japanese Women Risk Health for Quick Weight Loss with Diabetes Drug—But at What Cost?
A disturbing trend is sweeping across Japan, fueled by the power of social media and a culture obsessed with appearance. A drug originally approved for type 2 diabetes is now being misused by young individuals, particularly women, seeking rapid weight loss. This alarming practice has experts and medical professionals sounding the alarm, warning of severe health consequences associated with its off-label use. But here's where it gets controversial: is this a personal choice or a societal issue?
The drug, sold under the brand name Mounjaro, has gained popularity through social media platforms like TikTok, where influencers share their weight-loss journeys. One young woman in her 20s, working at a cabaret club in Osaka, recounted her experience after seeing an influencer’s transformation. Driven by the pressure to maintain a slim figure for her job, she purchased the medication online after a brief phone consultation. The result? She dropped to a weight of 42 kilograms at 160 centimeters tall, placing her in the underweight category. Yet, she felt compelled to continue due to societal and professional expectations. And this is the part most people miss: the psychological and physical toll of such extreme measures.
Another case involves a 35-year-old office worker who started using the drug to lose weight before her wedding, influenced by a nurse’s social media post. While these stories highlight individual choices, they also reveal a deeper issue: the growing reliance on online consultations, which often fail to provide a comprehensive health assessment. Professor Keiko Kishimoto, a social pharmacology expert, emphasizes that remote consultations limit doctors’ ability to accurately evaluate patients’ conditions. She also criticizes the unethical promotion of medications for non-medical purposes, a practice that has become increasingly common.
The risks are not just theoretical. A 22-year-old cabaret worker described frightening side effects after her first injection, including nausea, fever, and depression, which lasted for days. She decided to stop immediately, warning others against casual use. Yet, the allure of quick results persists, driven by societal pressures and the pervasive belief that thinness equals beauty. A 2024 health ministry survey revealed that one in five to six women in their twenties in Japan are underweight, a statistic that underscores the urgency of addressing this issue.
The Japan Society for the Study of Obesity has even proposed recognizing a new syndrome to describe health problems linked to being underweight and malnourished. They warn that social media and fashion magazines may be driving young women toward increasingly restrictive diets. Yoshifumi Tamura, from the My Well Body Council, advocates for media literacy education, pointing out that images on social media and in mainstream media are often edited or selective. He suggests that Japan should follow the lead of the U.S. and Europe by incorporating body image education into compulsory schooling.
Pharmaceutical companies have issued reminders that the drug’s safety and effectiveness are only confirmed for diabetes treatment, not weight loss. Additionally, those who misuse the drug may not qualify for support under Japan’s Relief Services for Adverse Health Effects system, leaving them vulnerable in case of complications.
This trend raises critical questions: Are we doing enough to challenge unrealistic beauty standards? How can we balance personal freedom with public health concerns? And what role should social media platforms play in regulating content that promotes harmful practices? Let’s start the conversation—what do you think?
